‘Men with prostate cancer high five-year survival rates, but they also have higher rates of non – cancer mortality than healthy individuals,’says study author Nancy Keating, assistant professor of health policy and medicine at Harvard Medical School. ‘This study shows that a common hormonal treatment for prostate cancer may put men significant risk for other serious diseases. Patients and physicians must be aware of the increased risk as they make treatment decisions what is the medicine ciprofloxacin used for . ‘.
Given the number of men receiving GnRH agonists, often saying for many months or years, these increased risks can have important implications for the health of prostate cancer survivors, Keating. Further studies are necessary to understand the biological mechanisms for this increased risk.
Stationary card also plans to Marketing Authorisation Application submit for PROMACTA in treating chronic ITP in Europe in the year 2008 , where it REVOLAD REVOLAD. Which connecting is being studied for long-term treatment of chronic ITP as well as thrombocytopaenia by hepatitis C virus liver cirrhosis and chemotherapy Induced Thrombocytopenia.
Observes to approval studies, which common side effects in patients receiving eltrombopag were headache, nausea, nasopharyngitis, diarrhea and vomiting.